ResMed Inc. (RMD)
NYSE: RMD · IEX Real-Time Price · USD
198.03
+1.70 (0.87%)
At close: Mar 28, 2024, 4:00 PM
197.47
-0.56 (-0.28%)
After-hours: Mar 28, 2024, 7:50 PM EDT
ResMed Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for ResMed stock have an average target of 207.8, with a low estimate of 169 and a high estimate of 260. The average target predicts an increase of 4.93% from the current stock price of 198.03.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ResMed stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Buy | 4 | 4 | 4 | 4 | 5 | 5 |
Hold | 3 | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 10 | 10 | 10 | 10 | 11 | 11 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Mizuho | Mizuho | Strong Buy Maintains $215 | Strong Buy | Maintains | $215 | +8.57% | Mar 27, 2024 |
Keybanc | Keybanc | Buy Initiates $227 | Buy | Initiates | $227 | +14.63% | Feb 6, 2024 |
Oppenheimer | Oppenheimer | Buy Maintains $185 → $205 | Buy | Maintains | $185 → $205 | +3.52% | Jan 30, 2024 |
Mizuho | Mizuho | Strong Buy Maintains $195 → $215 | Strong Buy | Maintains | $195 → $215 | +8.57% | Jan 30, 2024 |
Mizuho | Mizuho | Strong Buy Maintains $180 → $195 | Strong Buy | Maintains | $180 → $195 | -1.53% | Jan 26, 2024 |
Financial Forecast
Revenue This Year
4.68B
from 4.22B
Increased by 10.85%
Revenue Next Year
4.98B
from 4.68B
Increased by 6.28%
EPS This Year
7.53
from 6.09
Increased by 23.61%
EPS Next Year
8.21
from 7.53
Increased by 9.03%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 4.9B | 5.3B | 5.8B | 6.3B | 6.9B |
Avg | 4.7B | 5.0B | 5.3B | 5.6B | 6.2B |
Low | 4.5B | 4.3B | 4.3B | 4.6B | 5.7B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 16.9% | 13.2% | 16.7% | 19.3% | 23.9% |
Avg | 10.8% | 6.3% | 6.4% | 5.4% | 11.3% |
Low | 6.6% | -7.5% | -13.2% | -13.2% | 3.0% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 8.67 | 9.37 | 10.33 | 11.32 | 12.64 |
Avg | 7.53 | 8.21 | 8.98 | 9.52 | 11.22 |
Low | 7.09 | 7.18 | 7.37 | 7.87 | 9.98 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 42.4% | 24.4% | 25.9% | 26.1% | 32.7% |
Avg | 23.6% | 9.0% | 9.4% | 6.1% | 17.8% |
Low | 16.5% | -4.6% | -10.2% | -12.3% | 4.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.